Colon Cancer Misdiagnosis Attorneys

The difference between a Stage I diagnosis — where roughly nine in ten patients are alive five years later – and a Stage IV diagnosis – where fewer than one in seven survive to that mark – is the difference between a disease that is treated and a disease that kills.

Colorectal cancer spreads by local invasion through the bowel wall, by migration through lymphatic channels to regional lymph nodes (the pathway that moves a cancer from Stage II to Stage III), and by spreading through the bloodstream to distant organs, most commonly the liver, lungs, and peritoneum. Each of these pathways takes time. The window during which a cancer can be caught before it crosses from curable to incurable is real, and it can be closed by a physician who fails to act when a careful physician should.

Who Is Most at Risk? Risk Factors and Demographics

Colorectal cancer does not strike randomly. It follows patterns that physicians are trained to recognize and are expected to act upon. Age is the most significant single risk factor: the incidence of colon cancer rises sharply after age 45, and most cases are diagnosed in adults over 50. The United States Preventive Services Task Force (USPSTF) and the American Cancer Society have both set the recommended start age for routine screening at 45 for average-risk adults, a threshold that reflects the epidemiology of the disease. Black Americans develop colorectal cancer at higher rates and at younger ages than white Americans, and also face higher mortality — a disparity that makes age-appropriate and race-aware screening even more urgent for this population.

Family history is a critical risk amplifier. A patient with one first-degree relative diagnosed with colorectal cancer or an advanced adenoma has roughly double the average risk. The risk is higher still when the affected relative was diagnosed before age 50, or when multiple first-degree relatives are affected. Patients with known Lynch syndrome — an inherited mismatch repair gene mutation — face a lifetime risk of colorectal cancer that can exceed 50 percent. Patients with FAP have a near-certain lifetime risk if untreated.

Lifestyle and comorbid conditions also matter. Obesity, physical inactivity, heavy alcohol use, cigarette smoking, and a diet high in red and processed meats are all established risk factors, supported by decades of prospective epidemiological data. Patients with inflammatory bowel disease — Crohn’s disease and ulcerative colitis in particular — face elevated colorectal cancer risk that requires heightened surveillance, with colonoscopy intervals that differ from the general population guidelines.

Clinical Red Flags: Symptoms Physicians Must Not Dismiss

Colorectal cancer produces symptoms. Some appear early; others arise only as the disease progresses. In either case, a reasonably trained physician must recognize the clinical significance of what the patient is reporting and respond with appropriate and timely medical evaluation.

Rectal bleeding or blood in the stool.

Hematochezia — bright red blood passed with or separately from stool — is never normal in an adult and is never safely attributed to hemorrhoids without first ruling out a more serious cause in patients with risk factors or who are above average risk age. Melena (dark, tarry stools suggesting upper or lower GI blood loss) likewise demands investigation. The appropriate clinical response is a digital rectal examination, referral for colonoscopy, or at minimum a fecal occult blood test. The negligent response is to tell the patient they probably have hemorrhoids and to advise them to return if it does not resolve.

Unexplained iron-deficiency anemia.

Iron-deficiency anemia in an adult male at any age, or in a postmenopausal woman, has no dietary explanation and must be presumed to represent occult blood loss from the gastrointestinal tract until proven otherwise. The American Gastroenterological Association (AGA) and the American College of Gastroenterology (ACG) recommend colonoscopy for adults with new iron-deficiency anemia. A physician who prescribes iron supplements without investigating the source has provided inadequate care.

Change in bowel habits.

Persistent changes in stool caliber (pencil-thin stools), new-onset constipation or diarrhea lasting more than four to six weeks, or a sensation of incomplete bowel emptying (tenesmus) are all recognized warning signs. These symptoms can indicate a mass causing partial obstruction or mucosal irritation. The appropriate response is a thorough history, abdominal examination, and referral for colonoscopy, particularly in patients over 45 or those with risk factors. Attributing these symptoms to irritable bowel syndrome without ruling out malignancy may be negligent when the clinical picture does not fit and the risk profile demands further investigation.

Unintentional weight loss.

Weight loss of more than five percent of body weight over six to twelve months without an identified cause is a symptom that should prompt a systemic workup, including evaluation of the gastrointestinal tract. Combined with any of the above symptoms, unexplained weight loss in a patient of appropriate age or risk profile requires colonoscopy, not watchful waiting.

Abdominal pain or a palpable abdominal mass.

A mass palpated in the right lower quadrant or elsewhere in the abdomen is a finding that cannot be deferred. Persistent cramping or abdominal pain localized to the right or lower abdomen, particularly in the absence of another identified cause, warrants imaging and/or colonoscopy. A physician who does not document abdominal examination findings — or who performs none — in a patient with these complaints has failed the standard of care.

The Standard of Care: Clinical Guidelines Physicians Must Follow

In Pennsylvania and across the United States, the standard of care for colorectal cancer screening, diagnosis, and workup is defined by evidence-based guidelines issued by national medical organizations. These are not aspirational targets; they represent the minimum that a competent physician in the relevant specialty is expected to know and to practice.

The USPSTF, an independent panel of primary care physicians and prevention experts appointed by the Department of Health and Human Services, recommends that all adults at average risk begin colorectal cancer screening at age 45 and continue through age 75. Acceptable screening modalities include annual high-sensitivity guaiac fecal occult blood testing (gFOBT) or fecal immunochemical testing (FIT), multi-target stool DNA testing (Cologuard) every one to three years, CT colonography every five years, or colonoscopy every ten years. The USPSTF’s 2021 recommendation statement carries a Grade B recommendation for the 45–75 age group, meaning the evidence of benefit is substantial. A primary care physician who fails to offer or document any colorectal cancer screening discussion with an eligible patient has deviated from this standard.

The American Cancer Society similarly recommends screening starting at age 45 for average-risk adults and earlier for high-risk individuals. The American College of Gastroenterology (ACG) and the American Gastroenterological Association (AGA) provide detailed colonoscopy guidelines and specify surveillance intervals after polyp removal based on polyp size, number, and histology. Patients with tubular adenomas measuring 10mm or larger, or those with three or more adenomas, require a colonoscopy follow-up in three years — not ten. A gastroenterologist who schedules a routine ten-year interval after finding a high-risk polyp has failed to comply with ACG/AGA surveillance guidelines.

For patients with a first-degree family history of colorectal cancer or an advanced polyp, the ACG recommends beginning colonoscopy screening at age 40 — or ten years before the age at which the youngest affected relative was diagnosed, whichever comes first — and repeating every five years. A physician who fails to elicit, document, and act upon a family history of colorectal cancer has allowed a modifiable risk factor to go unaddressed.

Critically, a positive stool-based screening test — whether FIT, gFOBT, or stool DNA — is not a diagnosis of cancer, but it is a mandatory gateway to colonoscopy. The ACG and AGA are unambiguous: a positive stool-based test must be followed by colonoscopy, not by repeat stool testing. Any physician or practice that receives a positive stool test result and fails to refer the patient for colonoscopy within a reasonable timeframe — generally one to three months — has breached the standard of care. And any system that generates a positive result that is never communicated to the patient has failed at the most basic level of medical practice.

Common Mechanisms of Negligent Delay: Scenarios

Scenario 1: The Dismissed Symptom in Primary Care

A 49-year-old Black man visits his family physician with a complaint of intermittent rectal bleeding over the past two months. He mentions that his father had colon cancer at age 58. His physician attributes the bleeding to internal hemorrhoids, performs no digital rectal exam, and advises the patient to use over-the-counter hemorrhoid cream and return in six weeks if the bleeding continues. The patient returns four months later when the bleeding worsens; a colonoscopy finally reveals a Stage III sigmoid adenocarcinoma. At Stage I, the tumor would have been entirely resectable. The physician’s failure to perform a rectal exam, order a colonoscopy, or refer to gastroenterology given the patient’s age, race, symptoms, and family history was a departure from the standard of care that cost this man his chance at cure.

Scenario 2: The Positive FIT Result That Went Nowhere

A 54-year-old woman completes an annual fecal immunochemical test (FIT) mailed to her by her primary care practice’s preventive health program. The test returns positive. The result is uploaded to the electronic health record, flagged as abnormal — and never communicated to the patient. Eight months later, the patient schedules a routine physical and is told, for the first time, that her FIT had been positive. By then, she has developed new symptoms of abdominal pain and fatigue; colonoscopy reveals Stage III right-sided colon cancer with regional lymph node involvement. Both the physician and the practice are potentially liable: the physician for failure to review and act on the result, and the practice under a corporate negligence theory for failing to maintain a system ensuring abnormal results are communicated.

Scenario 3: The Radiologist Who Called It ‘Nonspecific’

A 61-year-old man undergoes a CT scan of the abdomen and pelvis for unrelated flank pain. The radiologist’s report notes ‘mural thickening of the ascending colon, nonspecific, consider follow-up imaging in six months.’ The referring emergency department physician reads only the negative findings relevant to the patient’s chief complaint and discharges the patient without communicating the incidental colonic finding. No follow-up imaging is scheduled; no colonoscopy is recommended. Sixteen months later, the patient is diagnosed with Stage IV right colon cancer with liver metastases. A competent radiologist would have recommended colonoscopy, not follow-up CT, for this finding. A competent emergency physician would have communicated the incidental finding to the patient’s primary care physician.

Scenario 4: The Gastroenterologist Who Did Not Complete the Colonoscopy

A 57-year-old woman undergoes a colonoscopy during which the gastroenterologist reaches the cecum but notes poor bowel preparation in the right colon, precluding adequate visualization of that segment. The procedure note documents ‘incomplete visualization of right colon due to poor prep’ — but the patient is told only that her colonoscopy was ‘normal’ and that she does not need another one for ten years. No repeat colonoscopy is recommended; no alternative imaging is ordered. Three years later, she is diagnosed with a large right-sided colon cancer — the very region that was not adequately examined. Failure to communicate the limitations of an incomplete study and to arrange appropriate follow-up is a well-recognized mechanism of diagnostic negligence.

Scenario 5: The Pathologist Who Missed a Malignancy

A 63-year-old man undergoes colonoscopy, during which his gastroenterologist removes several polyps including one large, sessile lesion in the sigmoid colon. The pathology report characterizes the specimen as ‘tubulovillous adenoma with high-grade dysplasia’ — a finding that requires close surveillance and possible surgical consultation. The gastroenterologist, reviewing the report quickly, schedules a routine three-year follow-up without discussing the significance of high-grade dysplasia with the patient. Two years later, the patient is diagnosed with invasive adenocarcinoma at the same site, now with lymph node involvement. Whether the original pathology reading underestimated an existing carcinoma, or whether the follow-up interval was inadequate, both the pathologist and the treating gastroenterologist may share liability for the delayed diagnosis.